1 / 1

Teratogenic risk from Tazarotenic acid in semen

Teratogenic risk from Tazarotenic acid in semen. 831 ng drug in semen which is about 1/ 5,000th of a single 4.5 mg capsule This is about 1/6,000 of the highest oral dose that was not teratogenic in animals.

kuame-barnett
Download Presentation

Teratogenic risk from Tazarotenic acid in semen

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Teratogenic risk from Tazarotenic acid in semen • 831 ng drug in semen which is about 1/ 5,000th of a single 4.5 mg capsule • This is about 1/6,000 of the highest oral dose that was not teratogenic in animals. • However, human may be more sensitive than animals. So instead of 1/6000 this may be only 1/600 to 1/16 human teratogenic dose based on data from other retinoids. Plus, the vaginal route may produce greater exposure to the fetus than the oral route. So this safety margin may be reduced even more.

More Related